This is a follow-up study of of a previous study which evaluated HPV type prevalence in residual cervical specimens from screening. The current study will measure the impact of HPV typing ollowing the introduction of the human papillomavirus vaccine. This study will collect leftover Pap specimens from the clinical lab and sending them to CDC for HPV typing.
HPV Impact Typing Study (HiTS) part II, 2015-2017
Investigator: Klein, Nicola
Funder: Centers for Disease Control and Prevention
